Makary Resigns as FDA Commissioner Following Policy Disputes - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

  • By

  • Kathryn Wighton

  • May 12, 2026

  • 2 min

Share

  • 1

    Marty Makary resigned as FDA Commissioner after 13 months, with Kyle Diamantas appointed as acting commissioner.

  • 2

    Makary's tenure included workforce reductions and significant turnover among senior FDA officials.

  • 3

    He opposed pediatric mask and vaccine mandates during the COVID-19 pandemic, criticizing CDC data reliance.

  • 4

    Makary focused on vaccine policy, food additive regulation, and dietary guidance, advocating for reduced processed food intake.

  • 5

    His resignation followed tensions over telehealth prescribing, regulatory review consistency, and flavored vaping product authorizations.

Original Source(s)

Makary Resigns as FDA Commissioner Following Policy Disputes

  • by Kathryn Wighton

  • May 12, 2026

Related Content

HBV vaccine policy shift may raise infections

A modeling study projects 83% more childhood chronic hepatitis B infections and 1.8 million susceptible young adults under a shared decision-making vaccination strategy.

FDA approves liquid cevimeline for Sjögren disease

The new oral solution offers an alternative to capsules for adults with dry mouth, including those with swallowing difficulties.

Medical Oddities: Alive, but convinced otherwise

A deadly conviction, healing vanilla, stormy lungs, and a COVID tea party await.